DIABETIC GLOMERULOPATHY: PATHOGENESIS AND MANAGEMENT

Diabetic Glomerulopathy: Pathogenesis and Management

Although not all renal disease that diabetic patients develop is due to diabetic glomerulosclerosis, the great majority of patients progressing to advanced renal failure suffer from diffuse or nodular (Kimmelstiel Wilson′s) diabetic glomerulosclerosis.This condition has become the single most frequent cause of end-stage renal failure in the

read more

University Teacher Training in Japan

La formación del profesorado universitario en Japón ha sido promovida en el marco del “Desarrollo profesional docente (FD)”.La formación del profesorado se convirtió en un "deber sustancial» para los profesores de los centros de pregrado por una orden ministerial en 2008 (en 2007 para los centros de pos

read more

Effect of Natural Nanostructured Rods and Platelets on Mechanical and Water Resistance Properties of Alginate-Based Nanocomposites

A series of biopolymer-based nanocomposite films were prepared by incorporating natural one-dimensional (1D) palygorskite (PAL) nanorods, and two-dimensional (2D) montmorillonite (MMT) nanoplatelets into sodium alginate (SA) film by a simple solution casting method.The effect of different dimensions of nanoclays on the mechanical, water resistance,

read more

Safety and Efficacy of Palbociclib and Radiation Therapy in Patients With Metastatic Breast Cancer: Initial Results of a Novel Combination

Purpose: Palbociclib is a selective cyclin-dependent kinase 4/6 inhibitor approved for metastatic ER+/HER2- breast cancer.Preclinical evidence suggests a possible synergistic effect of palbociclib when combined with radiation therapy (RT); however, the toxicity of this pairing is unknown.We report preliminary results on the use of this combination.

read more

Safety and Efficacy of Palbociclib and Radiation Therapy in Patients With Metastatic Breast Cancer: Initial Results of a Novel Combination

Purpose: Palbociclib is a selective cyclin-dependent kinase 4/6 inhibitor approved for metastatic ER+/HER2- breast cancer.Preclinical evidence suggests a possible synergistic effect of palbociclib when combined with radiation therapy (RT); however, the toxicity of this pairing is unknown.We report preliminary results on the use of this combination.

read more